1st Quarter - Report
PHARMATHENE, INC for PHARMATHENE, INC
Firm
Client
Income
—
Expenses
$192,731
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biodefense Advanced Research and Development Authority (BARDA-HHS) funding in Supplemental and FY-2010 Budget. Vaccines and Therapeutics for CBRN threats. Education of Congressional Members and Staff on biological-chemical terrorist threat to the U.S. FY-2010 Defense Appropriations requests for Chemical Nerve Agent Antidote and Anthrax Therapeutic Monoclonal Antibody
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EDWARD COOKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.